Cargando…
Pharmaceutical nanotechnology: which products are been designed against COVID-19?
The current pandemic COVID-19, caused by the SARS-CoV-2 virus, has been affecting thousands of people worldwide, promoting high numbers of deaths. With this, the world population is going through a process of changing habits, with social distance, improvement of hygiene techniques, to reduce the spr...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480001/ https://www.ncbi.nlm.nih.gov/pubmed/32922162 http://dx.doi.org/10.1007/s11051-020-05010-6 |
_version_ | 1783580352214728704 |
---|---|
author | Cavalcanti, Iago Dillion Lima Cajubá de Britto Lira Nogueira, Mariane |
author_facet | Cavalcanti, Iago Dillion Lima Cajubá de Britto Lira Nogueira, Mariane |
author_sort | Cavalcanti, Iago Dillion Lima |
collection | PubMed |
description | The current pandemic COVID-19, caused by the SARS-CoV-2 virus, has been affecting thousands of people worldwide, promoting high numbers of deaths. With this, the world population is going through a process of changing habits, with social distance, improvement of hygiene techniques, to reduce the spread of the SARS-CoV-2 virus and, consequently, reduce the number of hospitalized people in serious condition, as well as the mortality rate. This scenario has been promoting a continuous search for researchers, in the most varied areas, for possible methods of prevention or cure. Specifically, in the field of pharmaceutical nanotechnology, a variety of products are being developed against SARS-CoV-2. Under these circumstances, we propose here an exposition of some of the nanotechnological products (nanoscale between 1 to 1000 nm) currently designed for the detection of the virus, for the prevention and treatment of COVID-19, in addition to equipment for personal protection. We believe that pharmaceutical nanotechnology will be a valuable tool in the disease from the development of products that guarantee our protection against the SARS-CoV-2 virus. |
format | Online Article Text |
id | pubmed-7480001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-74800012020-09-09 Pharmaceutical nanotechnology: which products are been designed against COVID-19? Cavalcanti, Iago Dillion Lima Cajubá de Britto Lira Nogueira, Mariane J Nanopart Res Review Article The current pandemic COVID-19, caused by the SARS-CoV-2 virus, has been affecting thousands of people worldwide, promoting high numbers of deaths. With this, the world population is going through a process of changing habits, with social distance, improvement of hygiene techniques, to reduce the spread of the SARS-CoV-2 virus and, consequently, reduce the number of hospitalized people in serious condition, as well as the mortality rate. This scenario has been promoting a continuous search for researchers, in the most varied areas, for possible methods of prevention or cure. Specifically, in the field of pharmaceutical nanotechnology, a variety of products are being developed against SARS-CoV-2. Under these circumstances, we propose here an exposition of some of the nanotechnological products (nanoscale between 1 to 1000 nm) currently designed for the detection of the virus, for the prevention and treatment of COVID-19, in addition to equipment for personal protection. We believe that pharmaceutical nanotechnology will be a valuable tool in the disease from the development of products that guarantee our protection against the SARS-CoV-2 virus. Springer Netherlands 2020-09-09 2020 /pmc/articles/PMC7480001/ /pubmed/32922162 http://dx.doi.org/10.1007/s11051-020-05010-6 Text en © Springer Nature B.V. 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Cavalcanti, Iago Dillion Lima Cajubá de Britto Lira Nogueira, Mariane Pharmaceutical nanotechnology: which products are been designed against COVID-19? |
title | Pharmaceutical nanotechnology: which products are been designed against COVID-19? |
title_full | Pharmaceutical nanotechnology: which products are been designed against COVID-19? |
title_fullStr | Pharmaceutical nanotechnology: which products are been designed against COVID-19? |
title_full_unstemmed | Pharmaceutical nanotechnology: which products are been designed against COVID-19? |
title_short | Pharmaceutical nanotechnology: which products are been designed against COVID-19? |
title_sort | pharmaceutical nanotechnology: which products are been designed against covid-19? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480001/ https://www.ncbi.nlm.nih.gov/pubmed/32922162 http://dx.doi.org/10.1007/s11051-020-05010-6 |
work_keys_str_mv | AT cavalcantiiagodillionlima pharmaceuticalnanotechnologywhichproductsarebeendesignedagainstcovid19 AT cajubadebrittoliranogueiramariane pharmaceuticalnanotechnologywhichproductsarebeendesignedagainstcovid19 |